Acutus Medical, Inc. (AFIB)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Vince Burgess
Employees:
224
2210 FARADAY AVE, SUITE 100, CARLSBAD, CA 92008
442-232-6080

We are an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. Despite several decades of efforts by incumbents in this field, the clinical and economic challenges associated with arrhythmia treatment continue to be a huge burden for patients, providers and payors.

Data derived from most recent annual or quarterly report
Market Cap 15.039 Million Shares Outstanding27.953 Million Avg 30-day Volume 390.588 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-1.95
Price to Revenue2.2523 Debt to Equity0.5932 EBITDA-113.231 Million
Price to Book Value0.5684 Operating Margin-708.3444 Enterprise Value1.102 Million
Current Ratio6.031 EPS Growth-1.283 Quick Ratio4.481
1 Yr BETA 1.791 52-week High/Low 17.83 / 0.48 Profit Margin-740.6155
Operating Cash Flow Growth-7.5987 Altman Z-Score-7.299 Free Cash Flow to Firm -84.117 Million
Earnings Report2022-08-11
View SEC Filings from AFIB instead.

View recent insider trading info

Funds Holding AFIB (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AFIB BETA

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-06-24:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-21:
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-12:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.02: Results of Operations and Financial Condition
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-04-27:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 1.01: Entry into a Material Definitive Agreement
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-30:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-01-19:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-11-12:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-08-23:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-08-12:
    Item 2.02: Results of Operations and Financial Condition
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
  • 8-K: filed on 2021-07-12:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    60 Thousand total shares from 1 transactions

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    SHERIDAN JOHN F

    • Director
    35,547 2022-06-16 1

    HUENNEKENS R SCOTT

    • Director
    535,509 2022-06-16 2

    HINRICHS JAMES F.

    • Director
    95,910 2022-06-16 2

    CRAMP DANIELLA

    • Director
    31,223 2022-06-16 1

    BONITA DAVID P

    • Director
    • 10% Owner
    1,709,383 2022-06-16 2

    PELLEGRINI NIAMH LOUISE

    • Director
    32,172 2022-06-16 3

    ELBARDISSI ANDREW

    • Director
    32,022 2022-06-16 1

    MARZOUK SHADEN

    • Director
    32,022 2022-06-16 1

    ROMAN DAVID CHIEF FINANCIAL OFFICER

    • Officer
    183,355 2022-06-01 3

    BURGESS VINCENT J CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    61,469 2022-04-01 2

    MCQUILLAN STEVEN SVP, CLINICAL AFFAIRS & QA

    • Officer
    45,844 2022-04-01 3

    FLYNN JAMES E

    DEERFIELD MGMT III, L.P.

    DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

    DEERFIELD PRIVATE DESIGN FUND III, L.P.

    DEERFIELD MGMT L.P.

    DEERFIELD PARTNERS, L.P.

    • Director
    • 10% Owner
    • DIRECTOR BY DEPUTIZATIONDIRECTOR BY DEPUTIZATIONDIRECTOR BY DEPUTIZATIONDIRECTOR BY DEPUTIZATIONDIRECTOR BY DEPUTIZATIONDIRECTOR BY DEPUTIZATION
    5,415,449 2021-07-19 1

    ORBIMED ADVISORS LLC

    ORBIMED CAPITAL GP IV LLC

    ORBIMED ROF II LLC

    • Director
    • 10% Owner
    6,553,408 2021-07-19 1

    FLYNN JAMES E

    DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

    • Director
    • 10% Owner
    • DIRECTOR BY DEPUTIZATIONDIRECTOR BY DEPUTIZATION
    11,044 2021-06-17 1

    MALIK SHAHZAD

    • Director
    1,628,193 2021-06-17 0

    BARNICKEL JOHN CHIEF COMMERCIAL OFFICER

    • Officer
    13,966 2020-08-10 0

    DOHERTY GARY W. CHIEF FINANCIAL OFFICER

    • Officer
    0 2020-08-05 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    SHERIDAN JOHN F - Director

    2022-06-21 17:38:25 -0400 2022-06-16 A 19,600 a 19,600 direct

    MARZOUK SHADEN - Director

    2022-06-21 17:47:24 -0400 2022-06-16 A 19,600 a 19,600 direct

    MARZOUK SHADEN - Director

    2022-06-21 17:47:24 -0400 2022-06-16 A 8,400 a 12,422 direct -4.6794 0.0 1 -4.6794 2

    HUENNEKENS R SCOTT - Director

    2022-06-21 17:43:36 -0400 2022-06-16 A 19,600 a 19,600 direct

    HUENNEKENS R SCOTT - Director

    2022-06-21 17:43:36 -0400 2022-06-16 A 8,400 a 8,400 direct -4.6794 0.0 1 -4.6794 2

    HINRICHS JAMES F. - Director

    2022-06-21 17:45:41 -0400 2022-06-16 A 19,600 a 19,600 direct

    HINRICHS JAMES F. - Director

    2022-06-21 17:45:41 -0400 2022-06-16 A 8,400 a 61,311 direct -4.6794 0.0 1 -4.6794 2

    PELLEGRINI NIAMH LOUISE - Director

    2022-06-21 17:41:45 -0400 2022-06-16 A 19,600 a 19,600 direct

    PELLEGRINI NIAMH LOUISE - Director

    2022-06-21 17:41:45 -0400 2022-06-16 A 8,400 a 12,572 direct -4.6794 0.0 1 -4.6794 2

    SHERIDAN JOHN F - Director

    2022-06-21 17:38:25 -0400 2022-06-16 A 8,400 a 15,947 direct -4.6794 0.0 1 -4.6794 2

    CRAMP DANIELLA - Director

    2022-06-21 17:37:15 -0400 2022-06-16 A 19,600 a 19,600 direct

    CRAMP DANIELLA - Director

    2022-06-21 17:37:15 -0400 2022-06-16 A 8,400 a 11,623 direct -4.6794 0.0 1 -4.6794 2

    ELBARDISSI ANDREW - Director

    2022-06-21 17:35:18 -0400 2022-06-16 A 19,600 a 19,600 direct

    ELBARDISSI ANDREW - Director

    2022-06-21 17:35:18 -0400 2022-06-16 A 8,400 a 12,422 direct -4.6794 0.0 1 -4.6794 2

    BONITA DAVID P - Director - > 10% Owner

    2022-06-21 17:33:58 -0400 2022-06-16 A 19,600 a 19,600 direct

    BONITA DAVID P - Director - > 10% Owner

    2022-06-21 17:33:58 -0400 2022-06-16 A 8,400 a 12,422 direct -4.6794 0.0 1 -4.6794 2

    HUENNEKENS R SCOTT - Director by front foot trust

    2022-06-03 19:35:44 -0400 2022-06-03 S 60,000 $0.58 d 507,509 indirect -0.9724 -5.6726 7.6175 4 -5.6726 6

    ROMAN DAVID - Officer CHIEF FINANCIAL OFFICER

    2022-06-02 16:01:49 -0400 2022-06-01 A 100,000 a 183,355 direct 2.4917 6.3123 10.299 5 0.0 1

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ACUTUS MEDICAL INC AFIB 2022-06-24 22:15:03 UTC -31.0483 32.6183 100000
    ACUTUS MEDICAL INC AFIB 2022-06-24 21:45:03 UTC -31.0483 32.6183 100000
    ACUTUS MEDICAL INC AFIB 2022-06-24 21:15:04 UTC -31.0483 32.6183 100000
    ACUTUS MEDICAL INC AFIB 2022-06-24 20:45:03 UTC -32.2509 33.8209 100000
    ACUTUS MEDICAL INC AFIB 2022-06-24 20:15:03 UTC -32.2509 33.8209 100000
    ACUTUS MEDICAL INC AFIB 2022-06-24 19:45:03 UTC -32.2509 33.8209 100000
    ACUTUS MEDICAL INC AFIB 2022-06-24 19:15:03 UTC -32.2509 33.8209 100000
    ACUTUS MEDICAL INC AFIB 2022-06-24 18:45:03 UTC -32.2509 33.8209 100000
    ACUTUS MEDICAL INC AFIB 2022-06-24 18:15:04 UTC -32.2509 33.8209 100000
    ACUTUS MEDICAL INC AFIB 2022-06-24 17:45:03 UTC -32.2509 33.8209 100000
    ACUTUS MEDICAL INC AFIB 2022-06-24 17:15:03 UTC -32.2509 33.8209 100000
    ACUTUS MEDICAL INC AFIB 2022-06-24 16:45:03 UTC -34.84 36.41 60000
    ACUTUS MEDICAL INC AFIB 2022-06-24 16:15:03 UTC -34.84 36.41 60000
    ACUTUS MEDICAL INC AFIB 2022-06-24 15:45:03 UTC -34.84 36.41 35000
    ACUTUS MEDICAL INC AFIB 2022-06-24 15:15:03 UTC -34.84 36.41 3000
    ACUTUS MEDICAL INC AFIB 2022-06-24 14:45:03 UTC -33.6292 35.1992 3000
    ACUTUS MEDICAL INC AFIB 2022-06-24 14:15:03 UTC -33.6292 35.1992 100000
    ACUTUS MEDICAL INC AFIB 2022-06-24 13:45:03 UTC -33.6292 35.1992 100000
    ACUTUS MEDICAL INC AFIB 2022-06-24 13:15:03 UTC -33.6292 35.1992 100000
    ACUTUS MEDICAL INC AFIB 2022-06-24 12:45:03 UTC -33.6292 35.1992 100000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Prudential Investment Portfolios 12- PGIM QMA Large-Cap Core Equity Plus Fund AFIB -900.0 shares, $-15282.0 2021-06-30 N-PORT
    Prudential Investment Portfolios 12- PGIM QMA Long-Short Equity Fund AFIB -1900.0 shares, $-16796.0 2021-09-30 N-PORT

    Elevate your investments